Associated Papers
Association of lncRNA PRNCR1 polymorphisms with cancer susceptibility: a meta-analysis of the current literature.
Du P et al.
Journal of Genetics, 2021
Relationship between growth velocity and change of levels of insulin-like growth factor-1, insulin-like growth factor binding protein-3 and, IGFBP-3 promoter polymorphism during GnRH agonist treatment.
Park JH et al.
Annals of Pediatric Endocrinology & Metabolism, 2020
Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
Gao M et al.
Bmc Medical Genetics, 2018
Influence of The -202 A/C insulin-like growth factor-binding protein-3 promoter polymorphism on individual variation in height in Korean girls.
Yi MJ et al.
Annals of Pediatric Endocrinology & Metabolism, 2017
Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease.
Luttropp K et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2016
Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men.
Zhang G et al.
Oncotargets and Therapy, 2016
Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis.
Qie Y et al.
Oncotargets and Therapy, 2016
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.
Jallad RS et al.
Pituitary, 2015
Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma.
Zhao L et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2015
IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Xu J et al.
Genetics and Molecular Research : Gmr, 2015
Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer.
Ma X et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2015
Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.
Cartwright R et al.
European Urology, 2014
Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
Quan H et al.
Cell Biochemistry and Biophysics, 2014
IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.
Ding Q et al.
Urologia Internationalis, 2014
Maximal oxygen uptake is associated with allele -202 A of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism and (CA)n tandem repeats of insulin-like growth factor IGF1 in Caucasians from Poland.
Gronek P et al.
Acta Biochimica Polonica, 2014
The influence of promoter -202 A/C polymorphism (rs2854744) of the IGFBP-3 gene on erectile dysfunction risk and serum levels of IGF-I and IGFBP-3.
Safarinejad MR et al.
The Journal of Urology, 2013
Meta-analysis of the association between insulin-like growth factor binding protein 3 genetic polymorphisms and colorectal cancer susceptibility.
Xiang H et al.
Plos One, 2013
Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
Costalonga EF et al.
The Pharmacogenomics Journal, 2012
Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.
Xu L et al.
Molecular Carcinogenesis, 2012
Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC et al.
Clinical Endocrinology, 2012
Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.
Ribeiro RJ et al.
Plos One, 2012
The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR et al.
Archives of Toxicology, 2011
Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
Safarinejad MR
Bju International, 2011
Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR et al.
Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 2011
Association between insulin-like growth factor binding protein-3 promoter polymorphism of -1590 C>A and lung cancer susceptibility in a Chinese Han population.
Dai X et al.
Genetic Testing and Molecular Biomarkers, 2011
IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F et al.
Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 2010
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Dong X et al.
Gastroenterology, 2010
Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K et al.
Urology, 2010
Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies.
Chen W et al.
European Journal of Human Genetics : Ejhg, 2009
Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents.
Mong JL et al.
International Journal of Obesity (2005), 2009
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.
Hoyo C et al.
Journal of the National Medical Association, 2009
IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
D'Aloisio AA et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2009
The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF et al.
The Journal of Clinical Endocrinology and Metabolism, 2009
Insulin-like growth factor-I gene and insulin-like growth factor binding protein-3 polymorphism in patients with thyroid dysfunction.
Kursunluoglu R et al.
Archives of Medical Research, 2009
Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
Han SG et al.
Lung Cancer (amsterdam, Netherlands), 2008
Absence of association between SNPs in the promoter region of the insulin-like growth factor 1 (IGF-1) gene and longevity in the Han Chinese population.
Xie L et al.
Experimental Gerontology, 2008
Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2008
Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.
Paquette J et al.
Endocrinology, 2007
IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.
Hernandez W et al.
Carcinogenesis, 2007
Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.
Hoyo C et al.
Journal of the National Medical Association, 2007
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
Canzian F et al.
British Journal of Cancer, 2006
Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk.
Moon JW et al.
International Journal of Cancer, 2006
IGF-I and IGFBP-3 polymorphisms and risk of prostate cancer.
Friedrichsen DM et al.
The Prostate, 2005
IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White men.
Schildkraut JM et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2005
Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L et al.
Cancer Research, 2003